001060.KS JW Pharmaceutical Corporation Loading...

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
00:23
Feb 13
Kim Hyeong-cheol CEO, Kim Hyung-chul Research Institute 815 Money Talk (815머니톡)
JW Pharmaceutical shows earnings and volume breakout.
JW Pharmaceutical reported good earnings with unusual volume and rising R&D output; if the market begins to notice, the stock can move sharply.
001060.KS 1ST
MED

About 001060.KS Investor Commentary

Across the available history and selected sources, Buzzberg tracks 001060.KS (JW Pharmaceutical Corporation) across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: Kim Hyeong-cheol.